SXSW Insights: The future of AI in healthcare

SXSW Insights: The future of AI in healthcare
Preview
Source: FierceHealthcare
None
This week on “Podnosis,” we explore the pressing questions surrounding AI’s role in healthcare. From clinician trust to algorithm accuracy and patient privacy, there’s significant uncertainty about AI’s potential and impact in the healthcare sector, a topic that garnered considerable attention at this year’s South by Southwest conference.
During the annual event, American Medical Association President Jesse Ehrenfeld, M.D, and Claire Novorol, co-founder and CMO at Ada Health, both participated in a panel discussion on the future of AI in healthcare. Fierce’s Anastassia Gliadkovskaya caught up with them after the panel to gain further insights, and you’ll have the opportunity to hear those conversations in this week’s episode.
To learn more about the topics in this episode:
Google's healthcare AI ambitions: New model for personal health coaching and next steps for gen AI
How Epic is building out AI, ambient technology for clinicians
As AI adoption in healthcare grows, Senate lawmakers weigh regulation, payment approaches
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.